Speaker A
What if I told you there are five companies under $50 that could either fund your retirement or lose everything?
Discover 5 high-risk, high-reward stocks under $50 with potential to 10x or more, including Rocket Lab, AS Space Mobile, and more.
Key Takeaways
- Moonshot stocks under $50 can offer extraordinary returns but come with high risk and potential total loss.
- Diversify and limit position sizes to 1-5% of your portfolio to manage risk effectively.
- Key catalysts and timelines are critical to track for investment decisions in these companies.
- Invest only what you can afford to lose and use stop-loss strategies to protect capital.
- The biggest wealth often comes from revolutionary companies that many consider too risky.
Summary
- The video highlights five speculative stocks under $50 with potential for massive returns, comparing them to early Tesla and Amazon.
- Rocket Lab (RKB) is positioned as a strong SpaceX competitor with a key Neutron rocket launch expected in Q4.
- AS Space Mobile (AS) aims to provide 5G from space, targeting billions without reliable cell service, but faces unproven tech risks.
- Viking Therapeutics (VKTX) targets the obesity market with promising phase 3 trials and oral medication, competing with pharma giants.
- Beam Therapeutics (BAM) focuses on gene base editing to cure rare diseases, with potential FDA approvals and high risk.
- Jumia Technology (JMIA) is an African e-commerce leader with growth potential amid regional challenges like political instability.
- The presenter advises small position sizes (1-5%) due to high risk and recommends only investing money one can afford to lose.
- Key catalysts include Rocket Lab's Neutron launch, AS Space Mobile satellite deployments, and Viking Therapeutics' trial data.
- Moonshot investing is high risk with 60-70% failure rate, but a few successes can yield substantial portfolio gains.
- Portfolio construction tips emphasize diversification, risk management, and monitoring catalyst dates for these speculative stocks.
Full Transcript — Download SRT & Markdown
Speaker A
That's what Winston just said to me. And I'm talking about the next Tesla, Amazon, Netflix, companies that could 10x, 50x, even 100x your money. But here's the catch. Most of them will probably fail. I'm your retired investment banker, and today I'm sharing
Speaker A
five moonshot stocks that could change your life. But first, let me be crystal clear. These are high-risk speculative investments. You could lose 100% of your money. This is not financial advice. Only invest what you can afford to lose completely. And to make this a
Speaker A
little bit happier, I've created a free, like, 38-page workbook with detailed analysis of how to invest into these and any other moonshot stock. There is a link down below. It's felixfriends.org/moonshot.
Speaker A
Starts completely free just so you can get the most value out of this lesson.
Speaker A
But remember, this is educational right now. Here's what I learned investing over the last 20 years. The biggest wealth isn't created by safe, boring stocks. It's created by revolutionary companies that most people think are too risky. Amazon in 1997, it was $18,
Speaker A
$3,000 plus dollars today. If you take out the stock splits, 167 times return. Tesla in 2012, $35, about 250 bucks today, right? 7x return. The pattern, small companies, revolutionary technology, massive markets, under $50 stock prices. And today, I found five
Speaker A
companies that fit this profile. First up, we have Rocket Lab, ticker RKB, trading at about $45 right now. And the space economy is exploding. Literally $400 billion today heading to a trillion dollars by the end of the decade. And yes, SpaceX
Speaker A
dominates, but there is room for a strong number two player, not least because the government would like a strong number two player. So why could Rocket Lab potentially 10x? Well, they've done 60 successful launches. So they know what they're doing. They got a
Speaker A
billion-dollar order backlog. And the Neutron rocket launch in Q4, which is coming out shortly, is a SpaceX competitor. It is trading at a fraction of SpaceX's private valuation. I'm not a SpaceX shareholder. I've got some friends who are, and they're very, very
Speaker A
smug. Uh, and good for them. So, the catalyst here is the Neutron's, this new rocket's first launch in Q4. Success could send this to, you know, $100 or something. The risk: SpaceX is a monster competitor. Rocket failures destroy
Speaker A
companies overnight. My take, very small position for balanced investors, 1 to 3%. This is the safest moonshot on the list, by the way. Next, stock number two, AS Space Mobile, ticker AS, trading around $48. Imagine getting 5G service
Speaker A
on your regular phone from space. No cell towers needed. That's why this could be massive. Three billion people lack reliable connections. Space-based cellular is brand new and market partnerships with major telecom companies. 45 to 60 satellites are
Speaker A
going to be launched by next year. So the moonshot potential is if they execute this creates an entirely new industry. This could be a 20 to 50x return. The risk: unproven technology at scale. Satellite failures could kill the
Speaker A
company. My take: only for the most aggressive investors. And again, SpaceX is also in on this game. So big competitor, right? So for me, max one or 2% position sizing for something like this. Number three, Viking Therapeutics, ticker symbol VKTX,
Speaker A
trading around 40 bucks. The obesity crisis is creating a hundred billion dollar market. Zmpic and Regoi prove demand exists. Viking has the next generation solution. So why could ticker symbol VKTX explode? Well, the dual mechanisms are potentially better than
Speaker A
OMIC's oral formulation. Um, no injection needed also. And they have a phase three trial starting, $8 million in cash to fund development and a massive market with proven demand. What's the catalyst? There was a phase 2 oral data
Speaker A
point coming out October, November this year. Positive results could double the stock. The risk: they're competing against Eli Lilly and Novo Nordisk, giants with very, very deep pockets. So my take: probably the best risk-reward ratio on the list in my view. Um, I would
Speaker A
still go small, very small, 1 to 4% max depending on your risk tolerance and your stomach lining, um, health. Number four, Beam Therapeutics. Ticker symbol BAM, trading at around 18 bucks. They're not just treating diseases. They actually want to cure them. Base editing, gene
Speaker A
base editing is more precise than CRISPR, potentially fixing genetic diseases permanently. The opportunity: there are 7,000 rare diseases that affect 400 million people. They get FDA fast-track designation. Why? Because the FDA realizes you can't do a great big
Speaker A
study if only a couple of thousand people get this disease every year. So actually approval is easy and their treatment platform technology is applicable to multiple diseases.
Speaker A
One-time cures command very, very premium pricing. What is the timeline here for data? We get some in the second half of this year. Potential FDA approval for this thing called Beam 302. The risk: genetic medicine is kind of
Speaker A
experimental. There are safety issues like what if you grow an extra arm or something, you know. My take: well, probably the highest potential return and the highest risk and therefore smallest position size possible. Number five, Jumia Technology, ticker symbol
Speaker A
JMIA. And while everyone's focused on saturated western markets, Africa is digitizing. 1.4 billion people, growing middle class, 2% e-commerce penetration versus 15% everywhere else. So why is Jumia potentially huge? First mover advantage across 11 African countries.
Speaker A
They have an integrated platform, marketplace, payments, logistics. Sounds a bit like Amazon, doesn't it? Path to profitability by next year. A massive addressable market just getting started and the catalyst: well, if they get that profitability this year or next year,
Speaker A
that could trigger huge revaluation. The risk: yeah, political instability, currency devaluation, infrastructure challenges, and so on. So it's a geographic diversification if you want to be in the African market. Uh, so moonshot potential, yeah, small position sizing as always, 2
Speaker A
to 3%. So just a word then on portfolio construction before we round off here, how do we build a moonshot portfolio without actually going broke? So conservative approach is 2 to 5% of your entire portfolio goes into moonshots,
Speaker A
right? So you could say Rocket Lab 2%, VKTX 2%, 1% in cash looking for another moonshot, right? If you're a bit more risk hungry, 5 to 10% of the entire portfolio. So, you could take all five companies, put one or two, one or two percent in
Speaker A
each, or obviously find your own. Don't just buy what I'm talking about. Um, I wouldn't really go any higher than that.
Speaker A
And the reason is simple. If you have a stock that could 10x or 50x, why put everything up? Why not just put 1% on it? And if it 50xes, well, it's half your portfolio. You see what I'm saying?
Speaker A
It doesn't need to be a big position. The higher the risk, the smaller the position sizing. That is key. Only use money you can afford to lose. And set up a catalyst calendar to track the key dates which I'm about to give you here.
Speaker A
We'll try to put them on the screen. In Q4, we got Rocket Lab's Neutron launch.
Speaker A
ASTS puts out their first commercial satellites. VKTX has their phase 2 oral data. And then in 2026, we expect ASTS to deploy four full constellations of satellites. JMIA needs to be profitable. VKTX is going to have phase three results. And these dates are
Speaker A
literally going to make or break your investments if you choose to buy these. I'm not saying you should. So mark your calendars. And look, on a serious note, 60 to 70% of these companies will probably fail. That's the nature of
Speaker A
moonshot investing. But if just a couple of them succeed, they could potentially give you very, very nice results. Now, I always say you got to define your risk.
Speaker A
So you got to have a stop. You got to have position sizing that you can handle so tha
Speaker A
that no position ever stops you from being invested tomorrow and buying something else. I literally have made a 38page workbook on this with detailed analysis, risk assessment, but some portfolio templates and so on. It's free. Links in the description,
Speaker A
felix.org/moonshot. And if you enjoyed this video and that workbook, well, just share it with a friend and more people will hear the good stuff that Winston digs out while he's napping down there. He's doing some deep thinking. That's what that is.
Speaker A
Thanks for watching. The AI stocks with the most potential are not Nvidia or AMD or Intel or any of the software companies or even Palanteer in my humble opinion and of course Winston's research back there. It is the shovel play. What
Speaker A
does every AI company need? What do you need? No matter whether you buy Nvidia chips, AMD chips, ARM chips, Microsoft chips or whatever.
Topics:moonshot stockshigh risk investmentsRocket LabAS Space MobileViking TherapeuticsBeam TherapeuticsJumia Technologystock investing under 50speculative stocksinvestment portfolio
